| DB ID | MyCo_3896 |
| Title | Serum total IgE may be a biomarker among chronic pulmonary aspergillosis patients with elevated serum total IgE levels: A cohort study with pathological evaluations |
| Year | 2022 |
| PMID | 35098997 |
| Fungal Diseases involved | Chronic pulmonary aspergillosis |
| Associated Medical Condition | None |
| Genus | Aspergillus |
| Species | fumigatus |
| Organism | Aspergillus fumigatus |
| Ethical Statement | None |
| Site of Infection | None |
| Opportunistic invasive | None |
| Sample type | Body fluid |
| Sample source | Serum |
| Host Group | Human |
| Host Common name | Human |
| Host Scientific name | Homo sapiens |
| Biomarker Name | IgE |
| Biomarker Full Name | Immunoglobulin E |
| Biomarker Type | Diagnostic |
| Biomolecule | Protein |
| Geographical Location | Japan |
| Cohort | Here identified CPA cases from a list of patients at the National Hospital Organization Tokyo National Hospital who had used antifungal agents between April 2016 and September 2019. Antifungal agents were used in the study period, and we mea- sured the serum total IgE at least twice in 181 patients with CPA. |
| Cohort No. | 181 |
| Age Group | 47.8–74.3 |
| P Value | None |
| Sensitivity | None |
| Specificity | None |
| Positive Predictive Value | None |
| MIC | None |
| Fold Change | None |
| Pathway | None |
| Disease Introduction Mechanism | None |
| Technique | Immunological assay |
| Analysis Method | IgE immunofluorescence Analysis |
| ELISA kits | None |
| Assay Data | None |
| Validation Techniques used | IgE immunofluorescence Analysis |
| Up Regulation Down Regulation | Increase |
| Sequence Data | None |
| External Link | None |
